Your global observational studies
service provider

We offer a combination of world-class science, operations and technology to provide large and small pharma companies worldwide with real-world evidence for safety, market access and drug development.

SEND US YOUR RFI/RFP

OXON hits Lancet again with a cohort study on dementia

This cohort study clarifies the conflicting evidence of previous studies and identifies which lipid fractions are modifiable risk factors for Alzheimer´s dementia and which are not.

MORE INFORMATION

Design and delivery of RWE studies and late-phase research

Primary data collection and secondary data observational studies, synthesis research and statistics, data analysis & modelling

STUDY DESIGNS

Free Live Real-World Masterclass Series 2022-2023

How to ensure success and avoid pitfalls in
healthcare non-interventional RWE studies in Europe and Asia

PROGRAMME

CRO Services

As your Contract Research Organization, OXON helps plan and implement the generation of Real-World evidence for safety, market access/HEOR and drug development.

KNOW MORE

Late-phase studies

We help pharmaceutical, biotech and medical device companies to cost-effectively meet the requirements of late-phase clinical studies for better outcomes or greater value.

KNOW MORE

Therapeutic Areas

OXON offers proven experience and a large portfolio of studies in all major therapy areas, including orphan conditions, pregnancy, and risk minimization.

KNOW MORE

Real World Evidence and Late-Phase Research

OXON has been selected as a preferred provider by several big pharma companies.
With strong links to EMA and world-renowned academics and institutions in Europe and Asia for studies and teaching, OXON offers proven experience and a large portfolio of studies in all major therapeutic areas.

READ ABOUT US

OXON conducts:

• Primary data studies: prospective, registries, retrospective chart review, cross-sectional, surveys and pragmatic trials
• Secondary data studies: electronic records and registries
• Hybrid studies, including external controls for orphan medicines
• Synthesis research: systematic review and aggregate and IPD meta-analysis and landscaping
• Data analysis, modelling and simulation

World Class Science

Our specialization and high calibre allow us to have clear focus, deep expertise and superior insight to provide concrete results with maximum value to our clients.

Global Reach

We are specialised in multi-country observational studies and provide real-world evidence services worldwide with the expertise and multi-language capabilities of local partners.

Strong Links

OXON’s services are reinforced with academic links with the London School of Hygiene & Tropical Medicine and with leading academic methodological and clinical consultants.

Long Term Alliances

Our long-term alliance with a top tier global CRO provides us in-depth understanding of local requirements while keeping the flexibility needed to compete with the largest CROs.

We strive our best to support our clients in conducting cost-efficient observational studies worldwide

We pulled together
professionals and resources to serve you better

OXON IS YOUR OBSERVATIONAL STUDIES SERVICE PROVIDER

OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, >600 papers (100+ NEJM/Lancets)

REQUEST A MEETING

Newsroom

Read about us, our latest news and events

Your global observational studies
service provider

OXON hits Lancet again with a cohort study on dementia

Design and delivery of RWE studies and late-phase research